Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68K Sell
5
-2
-29% -$713 ﹤0.01% 732
2025
Q4
$2.2K Buy
7
+2
+40% +$634 ﹤0.01% 717
2025
Q3
$1.32K Buy
+5
New +$1.45K ﹤0.01% 743
2025
Q1
Sell
-7
Closed -$1.71K 160
2024
Q4
$1.71K Buy
7
+1
+17% +$297 ﹤0.01% 676
2024
Q3
$1.96K Hold
6
﹤0.01% 665
2024
Q2
$2.01K Sell
6
-2
-25% -$588 ﹤0.01% 653
2024
Q1
$2.4K Sell
8
-10
-56% -$2.93K ﹤0.01% 661
2023
Q4
$5.09K Buy
+18
New +$4.9K ﹤0.01% 549

Other funds holding AMGN

Caitlin John's AMGN Position: Q1 2026 in Review

Caitlin John reduced its Amgen (AMGN) stake by 29% in Q1 2026, selling an estimated $713 and leaving 5 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Caitlin John first reported a position in AMGN in Q4 2023 and has held it in 8 quarters since. The position peaked at $5.09K in Q4 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Caitlin John held 5 shares of Amgen worth $1.68K as of Q1 2026.
  • Caitlin John sold 2 Amgen shares in Q1 2026, an estimated $713.
  • Amgen made up ﹤0.01% of Caitlin John's portfolio in Q1 2026, its #732 holding.
  • Caitlin John first reported a position in Amgen in Q4 2023 and has held it in 8 quarters since.
  • Caitlin John's Amgen position peaked at $5.09K in Q4 2023.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.